Canada markets closed
  • S&P/TSX

    21,274.57
    -262.88 (-1.22%)
     
  • S&P 500

    4,577.11
    -85.74 (-1.84%)
     
  • DOW

    35,368.47
    -543.34 (-1.51%)
     
  • CAD/USD

    0.7997
    +0.0006 (+0.08%)
     
  • CRUDE OIL

    86.81
    +1.38 (+1.62%)
     
  • BTC-CAD

    53,034.54
    -60.50 (-0.11%)
     
  • CMC Crypto 200

    1,009.15
    -0.24 (-0.02%)
     
  • GOLD FUTURES

    1,814.80
    +2.40 (+0.13%)
     
  • RUSSELL 2000

    2,096.23
    -66.23 (-3.06%)
     
  • 10-Yr Bond

    1.8650
    +0.0930 (+5.25%)
     
  • NASDAQ futures

    15,231.75
    +25.75 (+0.17%)
     
  • VOLATILITY

    22.79
    +3.60 (+18.76%)
     
  • FTSE

    7,563.55
    -47.68 (-0.63%)
     
  • NIKKEI 225

    28,257.25
    -76.27 (-0.27%)
     
  • CAD/EUR

    0.7058
    +0.0057 (+0.81%)
     

AMRN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of December 23, 2021 in the Class Action Filed on Behalf of Amarin Corporation Plc Limited Shareholders

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

New York, New York--(Newsfile Corp. - November 30, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Amarin Corporation Plc (NASDAQ: AMRN) alleging that the Company violated federal securities laws.

Class Period: December 5, 2018 to June 21, 2021
Lead Plaintiff Deadline: December 23, 2021
No obligation or cost to you.

Learn more about your recoverable losses in AMRN:
https://www.kleinstocklaw.com/pslra-1/amarin-corporation-plc-loss-submission-form?id=21783&from=5

Amarin Corporation Plc NEWS - AMRN NEWS

CLASS ACTION CASE DETAILS: The filed complaint alleges that Amarin Corporation Plc made materially false and/or misleading statements and/or failed to disclose that: (i) there was an increasingly high risk that certain of Amarin's patents would be invalidated; (ii) once the District Court invalidated certain of Amarin's patents, there was little to no chance of reversing that ruling; (iii) the Company's litigation was preventing it from effectuating a successful takeover; (iv) Defendants were downplaying the true threat the ongoing abbreviated new drug application litigation posed to the Company's business and future prospects; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

WHAT THIS MEANS TO YOU AS A SHAREHOLDER: If you have suffered a loss in Amarin you have until December 23, 2021 to petition the court for lead plaintiff status. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU: If you purchased Amarin securities during the relevant period, you may be entitled to compensation without payment of any out-of-pocket fees.

HOW TO PROTECT YOUR FINANCIAL INTERESTS: For additional information about the AMRN lawsuit, please contact J. Klein, Esq. by telephone at 212-616-4899 or click this link.

ABOUT KLEIN LAW FIRM
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. The Klein Law Firm is a boutique litigation firm with experience in a wide range of areas including securities law, corporate finance and commercial litigation. Since 2011, our experienced attorneys have achieved superior results for our clients with a personalized focus. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/106020

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting